Progress made towards the development of a CMV peptide vaccine

This publication has 32 references indexed in Scilit:

• Relative dominance of HLA-B*07 restricted CD8+ T-Lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 alleles
  Human Immunology, 2003
• Use of Transgenic HLA A*0201/Kb and HHD II Mice To Evaluate Frequency of Cytomegalovirus IE1-Derived Peptide Usage in Eliciting Human CD8 Cytokine Response
  Journal of Virology, 2003
• Dynamics of CD4 and CD8 T Cell Responses to Cytomegalovirus in Healthy Human Donors
  The Journal of Infectious Diseases, 2002
• Intra‐abdominal Bacterial Infection Reactivates Latent Pulmonary Cytomegalovirus in Immunocompetent Mice
  The Journal of Infectious Diseases, 2002
• Identification of the HLA-A24 Peptide Epitope within Cytomegalovirus Protein pp65 Recognized by CMV-Specific Cytotoxic T Lymphocytes
  Viral Immunology, 2001
• Cytotoxic T Lymphocyte (CTL) Responses to Human Cytomegalovirus pp65, IE1‐Exon4, gB, pp150, and pp28 in Healthy Individuals: Reevaluation of Prevalence of IE1‐Specific CTLs
  The Journal of Infectious Diseases, 2000
• Distribution of human CMV-specific memory T cells among the CD8pos. subsets defined by CD57, CD27, and CD45 isoforms
  European Journal of Immunology, 1999
• The role of the conserved residue in pocket A and the polymorphic residue in pocket E of HLA-B*3501 in presentation of human minor histocompatibility peptides to T cells
  International Immunology, 1994
• Ontogeny of glycoprotein gB-specific antibody and neutralizing activity during natural cytomegalovirus infection
  Journal of Medical Virology, 1994
• High expression of human cytomegalovirus (HCMV)-gB protein in cells infected with a vaccinia-gB recombinant: the importance of the gB protein in HCMV immunity
  Vaccine, 1991